Joint WHO/Europe–ECDC Annual European Influenza Surveillance Meeting, 2018
The joint annual influenza surveillance meeting by ECDC and the WHO Regional Office for Europe took place on 6 - 8 June 2018 in Copenhagen, Denmark. Invited participants were epidemiological and virological surveillance experts nominated by national health authorities as well as representatives from international institutions, covering the 53 countries of the EU/EEA and the WHO European region. The meeting was by invitation only.
Acute respiratory pandemics: how to plan for and manage
This practical course will cover outbreak investigation, pandemic planning, recent developments in respiratory pathogen biology and therapy, and will focus around two practical scenarios in which participants will gain experience in managing an acute epidemic. Research during an epidemic and ethical aspects will also be covered.
ERS Training Course: Acute respiratory pandemics: how to plan and manage
This practical course covered outbreak investigation, pandemic planning, recent developments in respiratory pathogen biology and therapy, and focused around two practical scenarios in which participants could gain experience in managing an acute epidemic.
WHO announcement of strains to be included in the Southern Hemisphere 2013 influenza vaccine compositionArchived
Following a meeting of the global influenza collaborating centres in Beijing hosted by the newest Centre that in China the World Health Organization (WHO) recently recommended that influenza vaccines to be used in the 2013 Southern Hemisphere (SH) influenza season should contain the same three strains as the vaccines that now are being used in the Northern Hemisphere (NH).
No association found between pandemic influenza vaccination and Guillain-Barre Syndrome in EuropeArchived
Due to an association that was observed in the United States between a swine-flu based human influenza vaccine developed in 1976 and the disease acute polyneuropathy Guillain-Barré syndrome (GBS) (1,2), GBS was one of the adverse events that was monitored in Europe and North America (3) following the 2009 influenza pandemic vaccination campaigns.